Alliance for Regenerative Medicine · 1 week ago
Vice President Government Affairs
Washington, DC
Full-time
Hybrid
Director/Executive
$270K/yr - $300K/yr
10+ years expThe Alliance for Regenerative Medicine (ARM) is a leading international advocacy organization focused on engineered cell therapies and genetic medicines. The Vice President of US Government Affairs will be responsible for Federal Advocacy, US Alliance Development, and Policy functions, driving stakeholder engagement and advocacy strategies to align with ARM's goals.
Health Care
Responsibilities
Lead the tactical execution of ARM’s mission and core Congressional and various Agency components of the Alliance’s long-term strategic plan for the US
Leverage one’s understanding of the external environment to identify possibilities and create opportunities for the CGT Sector
Drive the development of stakeholder engagement and advocacy strategies (including developing and fostering strong relationships with Congress and the Executive Branch), in partnership with Communications, Policy, and member-company leadership, to achieve ARM’s advocacy goals
Help to safeguard the Alliance’s reputation and building an ambassadorship among the ARM membership
Successfully deliver a clear and integrated engagement strategy, ensuring that ARM and its membership are aligned in communicating and helping shape the environment in support of (1) patient access in the payer and regulatory domains (2) adequate reimbursement for innovative technology and (3) advancing initiatives which would ensure the sustainable economic expansion and competitiveness – as well as US leadership in scientific application and technological development of the CGT Sector
Partner with other departments within ARM to ensure the organization continues to grow, well-represent the interests of our Membership, and remain a catalyst for the broader CGT community; this includes partnering with Regulatory Policy, Scientific Affairs, Membership and Events, General and Administrative, and other functions across ARM
Other duties as assigned
Qualification
Required
BS or BA required
Minimum of 10 years of management or consulting experience in federal government affairs – with particular emphasis on engagement within the Department of Health & Human Services and related oversight Congressional Committees
Demonstrated ability to successfully establish and achieve quantitative metrics for the US Government Affairs team
In-depth understanding of reimbursement, market development, drug approval process, and other relevant regulatory issues affecting global competitiveness of the pharmaceutical-biotechnology sector, especially innovative CGT technologies
The desire and the ability to investigate, learn, and master subject matter areas in which they are not currently knowledgeable. The candidate is committed to drawing from the experience of others
Demonstrated affinity for processing complex information and summarizing it concisely in writing and/or verbally in a professional and time-sensitive manner
Demonstrated ability to coach and develop staff within ARM
Demonstrated ability to expand ARM's federal Political Action Committee (PAC)
Executive presence with the ability to establish a high degree of emotional intelligence skills in engaging across senior ARM Leadership, BOD, and member-company leads
Proven track record of exceptional teamwork, communication, and relationship management skills (including proven ability to lead and manage contract consultants)
Unwavering commitment to ARM's mission, long-term strategic plan, and ARM's core values
Preferred
MBA, MPH, JD, or other advanced degree
Previous experience within a corporate federal government affairs function or DC–based biotech/pharma industry associations
Benefits
Health insurance
Dental insurance
Vision insurance
Life Insurance
Short-term disability
Long-term disability
Pet insurance
Company
Alliance for Regenerative Medicine
The Alliance for Regenerative Medicine (ARM) is the leading international advocacy organization championing the benefits of engineered cell therapies and genetic medicines for patients, healthcare systems, and society.
11-50 employees
Funding
Current Stage
Early StageLeadership Team
Brett Kopelan
Board Member
Janet Lynch Lambert
Advisor
Recent News
BioWorld Financial Watch
2026-01-16
2025-11-23
2025-11-10
Company data provided by crunchbase